Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M DeAngelis

Showing results (101-110 of 583) with videos related to

Pageof 59
Sort By:
Blood Reviews|December 3, 2014
The double-edged sword: Neurotoxicity of chemotherapyRajiv S Magge, Lisa M DeAngelis
Stem Cell Investigation|December 23, 2017
Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degenerationLindsay A Farrer, Margaret M DeAngelis
Neurology|August 29, 2007
Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiformeSean A Grimm, Lisa M DeAngelis
Hematology. American Society of Hematology. Education Program|November 25, 2006
An update on therapy of primary central nervous system lymphomaLisa M Deangelis, Fabio M Iwamoto
Neurology|May 23, 2007
Chemotherapy for low-grade gliomas: emerging consensus on its benefitsPatrick Y Wen, Lisa M DeAngelis
British Journal of Haematology|January 28, 2009
Therapy of chemotherapy-induced peripheral neuropathyThomas J Kaley, Lisa M Deangelis
Continuum (Minneapolis, Minn.)|April 4, 2015
Neurologic complications of chemotherapy and radiation therapyCraig P Nolan, Lisa M DeAngelis
International Journal of Molecular Sciences|August 23, 2013
Molecular interactions in the development of brain metastasesNina Martinez, Adrienne Boire, Lisa M Deangelis
Journal of Neuro-Oncology|February 1, 2014
Methotrexate re-challenge for recurrent primary central nervous system lymphomaElena Pentsova, Lisa M Deangelis, Antonio Omuro
Neurology|November 27, 2002
Primary CNS lymphoma: a whole-brain disease?Rose Lai, Marc K Rosenblum, Lisa M DeAngelis
Pageof 59

Showing results (101-110 of 583) with videos related to

Sort By:
Pageof 59
Blood Reviews|December 3, 2014
The double-edged sword: Neurotoxicity of chemotherapyRajiv S Magge, Lisa M DeAngelis
Stem Cell Investigation|December 23, 2017
Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degenerationLindsay A Farrer, Margaret M DeAngelis
Neurology|August 29, 2007
Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiformeSean A Grimm, Lisa M DeAngelis
Hematology. American Society of Hematology. Education Program|November 25, 2006
An update on therapy of primary central nervous system lymphomaLisa M Deangelis, Fabio M Iwamoto
Neurology|May 23, 2007
Chemotherapy for low-grade gliomas: emerging consensus on its benefitsPatrick Y Wen, Lisa M DeAngelis
British Journal of Haematology|January 28, 2009
Therapy of chemotherapy-induced peripheral neuropathyThomas J Kaley, Lisa M Deangelis
Continuum (Minneapolis, Minn.)|April 4, 2015
Neurologic complications of chemotherapy and radiation therapyCraig P Nolan, Lisa M DeAngelis
International Journal of Molecular Sciences|August 23, 2013
Molecular interactions in the development of brain metastasesNina Martinez, Adrienne Boire, Lisa M Deangelis
Journal of Neuro-Oncology|February 1, 2014
Methotrexate re-challenge for recurrent primary central nervous system lymphomaElena Pentsova, Lisa M Deangelis, Antonio Omuro
Neurology|November 27, 2002
Primary CNS lymphoma: a whole-brain disease?Rose Lai, Marc K Rosenblum, Lisa M DeAngelis
Pageof 59